Pfizer Postdoctoral Program in Neuroscience

-
Pfizer Neuroscience Postdoctoral

Fellowship Program www.pfizerneuroscience.com Based in scenic
Groton, Connecticut, the Pfizer Neuroscience Fellowship Program provides an
unparalled opportunity for young scientists interested in understanding
brain disorders and translating knowledge into innovative medicines. We
seek motivated and enthusiastic individuals with a demonstrated track record
in basic or translational neuroscience interested in pursuing an
academic-style postdoc in an industry setting. Successful candidates will
come from a range of backgrounds including molecular/cellular biology,
protein biochemistry, in vitro and in vivo electrophysiology, imaging,
systems neuroscience, animal models, and behavioral/cognitive neuroscience.

At Pfizer, there are extensive programs in molecular/cellular neuroscience,
synapse biology, and pharmacology. Moreover, there is a vibrant in vivo
electrophysiology program for cognition, extensive behavioral models,
imaging platforms, and essentially limitless access to chemical biology and
animal models. In addition, postdocs at Pfizer get exposed to the art and
science of drug discovery, with first hand ability to interact with programs
working to develop new medicines.
 

Applications are accepted throughout the year with reviews and interviews occurring in the fall and spring. For the fall review, applications are due October 1st and interviews will be conducted early in November. Candidates will be contacted by October 15th if they have been selected for an interview. The application deadline for the spring review will be April 1st and interviews will be scheduled in May. Interested candidates should apply at the link below, making sure to submit a resume and a summary of research interests (2-3 pages in length). In addition, please have three letters of recommendation emailed directly to Kate Yannacci at kate.m.yannacci@pfizer.com. Details on the Pfizer Neuroscience Postdoctoral Program can be found at www.pfizerneuroscience.com.


Apply to the postdoc program:
Applications are reviewed on a regular basis and top candidates are invited to visit, present their research, and interview at Pfizer's Groton Research Campus. More extended descriptions of the interview process will be provided to the invited candidates at the time of invitation.


Apply Now


Comments

Unknown said…
Glycomet 1000mg Tablet is an oral enemy of diabetic medication containing metformin as a functioning ingredient. The medication utilized is for the treatment of type 2 diabetes mellitus. This Tablet SR is best taken with food to stay away from sickness and abdominal agony. You should take it regularly, simultaneously every day, to get the most advantage.
April 6, 2022 at 10:32 AM
Post a Comment

Popular posts from this blog

Sequence Analysis is still sexy:Dual Descriptor Method for Biological Sequence Analysis

-
The emergence of “Systems Biology” in recent years highlights the systematic viewpoint of bio-system modeling. Building on such a background, Dual Descriptor Method, a generic methodology for biological sequence analysis is proposed. From a systematic perspective, Dual Descriptor is defined as a two element set of Composition Weight Map and Position Weight Function which aim at reflecting the composition and permutation information of a sequence. An alternate training algorithm is provided to get an optimum description of the building patterns of the sequences. In this paper , dual descriptor method has been applied to the analysis of two typical problems of molecular biology: gene identification and the prediction of protein function. Satisfactory and insightful results are achieved. Owing to the generality of this methodology, dual descriptor method has wide application perspective for many problems of pattern recognition, especially those involved in “Systems Biology”. Be a part of
Read more

Abbott Laboratories Buys Piramal Healthcare Limited Biz for $3.72B

-
Abbott May 21 announced a definitive agreement with Piramal Healthcare Limited to acquire full ownership of Piramal's Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for an up-front payment of $2.12 billion , plus $400 million annually for the next four years, giving Abbott the No. 1 position in the Indian pharmaceutical market. This further accelerates Abbott's emerging markets growth following the recent acquisition of Solvay Pharmaceuticals and announcements last week of Abbott's collaboration with Zydus Cadila as well as the creation of a new stand-alone Established Products Division to focus on expanding the global markets for its leading branded generics portfolio. "This strategic action will advance Abbott into the leading market position in India , one of the world's most attractive and rapidly growing markets," said Miles D. White , chairman and chief executive officer, Abbott. &quo
Read more

List of Cheminformatics Companies & Institutions

-
Accelrys ACD/Labs (Advanced Chemistry Development, Inc.) Afferent Systems Inc. Agilent Technologies Aureus Pharma Barnard Chemical Information Ltd. (John Barnard and Geoff Downs) SEE: digital chemistry Bio-Rad Laboratories BioReason BioSolveIT BlueObelisk.org Bruker Daltonics Inc. Cambridge Crystallographic Data Centre CambridgeSoft Corporation CARB Center for Advanced Research in Biotechnology (NIST/University of Maryland) Cengent Therapeutics (Genes to Leads). Acquired by Inncardio, Inc. Center for Molecular Modeling (NIH) Centre for Molecular and Biomolecular Informatics CMBI (formerly: CAOS/CAMM: Dutch National Center for Computer-Assisted Chemistry and Molecular Modelling) Cerep ChemAxon ChemDiv, Inc. (Chemical Diversity) Chemical Abstracts Service Chemical Computing Group, Inc. Chemical Simulations Group ChemInnovation Software ChemNavigator ChemSW (Chemistry Software for Windows, formerly: WindowChem) Chenomx Inc. CIS Chemical Information System CombiChem.net CompuChem C
Read more